vimarsana.com
  1. Home
  2. Live Updates
  3. Radius Pharmaceuticals Inc - Breaking News

Radius Pharmaceuticals Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RADIUS ANNOUNCES ROYALTY PURCHASE AGREEMENT WITH DRI HEALTHCARE TO SELL A PORTION OF ITS ROYALTY AND COMMERCIAL MILESTONE INTEREST IN ELACESTRANT FOR UP TO $140 MILLION RADIUS RETAINS THE RIGHTS TO RECEIVE OVER $200 MILLION IN COMMERCIAL MILESTONES

RADIUS RETAINS THE RIGHTS TO RECEIVE OVER $200 MILLION IN COMMERCIAL MILESTONES Boston, Mass. - Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. , a specialty. -Today at 11:27 am- MarketScreener

United statesSara goldbergSwaine mooreScot briggsBehzad khosrowshahiDrug administrationCommittee for medicinal products human useRadius pharmaceuticals incRadius health incKirkland ellisRopes grayMenarini groupEuropean medicines agencyMenarini group companyRoyalty purchase agreementChief executive officer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.